Back to tracker

PCI Pharma Services, a Philadelphia contract drug manufacturer, invested in a 200,000-square-foot manufacturing facility in Rockford. The site will enhance the company’s ability to create a variety of injectable biologic drugs, including those that treat diabetes, obesity, cancer and autoimmune disease, and also have product testing capabilities, on-site cold storage, and packaging and labeling machines.

Year Relocated: 2023

Amount in Capital Investment: $50,000,000